Predictive Risk Factors of Pancreatic Exocrine Insufficiency Developed After Acute Pancreatitis: A Retrospective Cohort Study
- PMID: 36950051
- PMCID: PMC10025014
- DOI: 10.2147/JIR.S392932
Predictive Risk Factors of Pancreatic Exocrine Insufficiency Developed After Acute Pancreatitis: A Retrospective Cohort Study
Abstract
Purpose: The aim of this study was to compare the clinical characteristics of acute pancreatitis (AP) patients between those who developed pancreatic exocrine insufficiency (PEI) and those who did not, and to investigate the predictive factors of PEI.
Patients and methods: From October 1st 2019 to July 30th 2021, AP patients admitted at our center were included. The fecal elastase-1 assay was adopted for PEI diagnosis. The clinical characteristics, treatments, and outcomes between the patients with and without PEI were analyzed.
Results: In total, 63 males and 42 females were included. There were 27 patients with mild AP, 54 with moderately severe AP, and 24 with severe AP. The median modified computed tomography severity index (MCTSI) was 6.000(4.000, 8.000). During the follow-up, 38 patients developed PEI after AP. The univariate analysis showed that higher ASA grade (P = 0.006), more severe AP (P = 0.000), the presence of multiple organ dysfunction syndrome (P = 0.030), higher MCTSI (P = 0.000), the development of infected pancreatic necrosis (P = 0.002) and local complications (P = 0.000), higher levels of triacylglycerol (P = 0.022), video-assisted retroperitoneal debridement intervention (P = 0.015), and longer intensive care unit stay (P = 0.044) were correlated with PEI development. Furthermore, the logistic regression analyses showed that MCTSI during hospitalization is an independent risk factor for PEI development during the AP recovery period.
Conclusion: ASA grade, severity of AP, multiple organ dysfunction syndrome, MCTSI, infected pancreatic necrosis, local complications, higher levels of triacylglycerol, video-assisted retroperitoneal debridement intervention, and longer intensive care unit stay were potentially associated with PEI development during the AP recovery period. High MCTSI was independently associated with the development of PEI during the AP recovery period, which may help alert to the possibility of PEI to help with its early detection and treatment.
Keywords: acute pancreatitis; fecal elastase-1; modified computed tomography severity index; pancreatic exocrine insufficiency.
© 2023 Guo et al.
Conflict of interest statement
The authors have no competing interests to declare.
Similar articles
-
[Evaluation of severity and prognosis of acute pancreatitis by CT severity index and modified CT severity index].Zhonghua Yi Xue Za Zhi. 2022 Jul 12;102(26):2011-2017. doi: 10.3760/cma.j.cn112137-20220424-00914. Zhonghua Yi Xue Za Zhi. 2022. PMID: 35817726 Chinese.
-
Pancreatic exocrine insufficiency, diabetes mellitus and serum nutritional markers after acute pancreatitis.World J Gastroenterol. 2014 Dec 28;20(48):18432-8. doi: 10.3748/wjg.v20.i48.18432. World J Gastroenterol. 2014. PMID: 25561813 Free PMC article.
-
Predictive value of the C-reactive protein/albumin ratio in severity and prognosis of acute pancreatitis.Front Surg. 2023 Jan 10;9:1026604. doi: 10.3389/fsurg.2022.1026604. eCollection 2022. Front Surg. 2023. PMID: 36704518 Free PMC article.
-
Potential for Screening for Pancreatic Exocrine Insufficiency Using the Fecal Elastase-1 Test.Dig Dis Sci. 2017 May;62(5):1119-1130. doi: 10.1007/s10620-017-4524-z. Epub 2017 Mar 17. Dig Dis Sci. 2017. PMID: 28315028 Review.
-
Pancreatic exocrine insufficiency and Crohn's disease.Minerva Gastroenterol Dietol. 2020 Mar;66(1):17-22. doi: 10.23736/S1121-421X.19.02636-9. Epub 2019 Nov 20. Minerva Gastroenterol Dietol. 2020. PMID: 31760738 Review.
References
-
- Domínguez-Muñoz J, Iglesias-García J, Iglesias-Rey M, et al. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three-way crossover study. Aliment Pharmacol Ther. 2005;21:993–1000. doi:10.1111/j.1365-2036.2005.02390.x - DOI - PubMed
LinkOut - more resources
Full Text Sources